SUTENT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug SUTENT contains one active pharmaceutical ingredient (API):

1	Sunitinib UNII LVX8N1UT73 - SUNITINIB MALATE
	Sunitinib inhibits multiple RTKs that are implicated in tumour growth, neoangiogenesis, and metastatic progression of cancer.
	Read more about Sunitinib

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SUTENT Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01EX01	Sunitinib	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10004M, 10009T, 10010W, 10459L, 10464R, 10473F, 10503T, 10504W, 11250D, 11253G, 11256K, 11266Y, 2837H, 2842N, 2959R, 9417P, 9418Q, 9419R, 9420T, 9421W, 9422X, 9488J, 9489K, 9490L
BR	Câmara de Regulação do Mercado de Medicamentos	522720050087617, 522720050087717, 522720050087817
CA	Health Products and Food Branch	02280795, 02280809, 02280817
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.733-06-07, 27.734-1-03-12, 27.738-06-07
EE	Ravimiamet	1257982, 1257993, 1258006, 1353282, 1353293, 1353305, 1426632, 1426643
ES	Centro de información online de medicamentos de la AEMPS	06347001, 06347002, 06347003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	099863, 099872, 099881
FR	Base de données publique des médicaments	63841059, 65283820, 69225978
GB	Medicines & Healthcare Products Regulatory Agency	136358, 136363, 136365
HK	Department of Health Drug Office	55404, 55405, 55406, 59785
IE	Health Products Regulatory Authority	88684, 88685, 88686
IL	מִשְׂרַד הַבְּרִיאוּת	6045, 6046, 6047
IT	Agenzia del Farmaco	037192010, 037192022, 037192034
JP	医薬品医療機器総合機構	4291018M1029
LT	Valstybinė vaistų kontrolės tarnyba	1030588, 1030589, 1030590, 1030591, 1030592, 1030593, 1038372, 1038373, 1060892, 1061423
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	233M2006
NL	Z-Index G-Standaard, PRK	83453, 83461, 83488
NZ	Medicines and Medical Devices Safety Authority	12700, 12701, 12702, 17938
PL	Rejestru Produktów Leczniczych	100114829, 100116923, 100118520, 100214933
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65026001, W65027001, W65028001
SG	Health Sciences Authority	13254P, 13255P, 13256P, 13920P
TN	Direction de la Pharmacie et du Médicament	8013061H, 8013062H, 8013063H
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308157553, 8681308158994, 8681308159427, 8681308159434, 8681308159571
US	FDA, National Drug Code	0069-0550, 0069-0770, 0069-0830, 0069-0980
ZA	Health Products Regulatory Authority	41/26/0195, 41/26/0196